| Pharmaceutical Information |
| Drug Name |
Lomitapide mesylate |
| Drug ID |
BADD_D01312 |
| Description |
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH) patients. It is marketed under the name Juxtapid (R). |
| Indications and Usage |
Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C). |
| Marketing Status |
approved; investigational |
| ATC Code |
C10AX12 |
| DrugBank ID |
DB08827
|
| KEGG ID |
D09638
|
| MeSH ID |
C473731
|
| PubChem ID |
11274333
|
| TTD Drug ID |
D0H8VY
|
| NDC Product Code |
76431-110; 76431-120; 11014-0361; 11014-0460; 11014-0360; 66039-923; 76431-130; 11014-0362; 11014-0461; 48957-0086; 76431-105; 11014-0359; 11014-0459; 70600-005 |
| UNII |
X4S83CP54E
|
| Synonyms |
BMS201038 | BMS-201038 | BMS 201038 | lomitapide | Juxtapid | AEGR 733 | AEGR733 | AEGR-733 |
|
| Chemical Information |
| Molecular Formula |
C40H41F6N3O5S |
| CAS Registry Number |
202914-84-9 |
| SMILES |
CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6
=CC=CC=C64)C(=O)NCC(F)(F)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
